Library · Immune · Respiratory immune system support and regulation
Bronchogen (Ala-Glu-Asp-Leu)
Ala-Glu-Asp-Leu, AEDL peptide, Bronchial epithelium peptide
Synthetic tetrapeptide (Ala-Glu-Asp-Leu) from Russian “peptide bioregulator” research, intended to support respiratory function and studied there for bronchitis and asthma. Lacks recent international clinical research and is not FDA/EMA approved; sold online as a supplement or research chemical.
Research score 70/100. Reference only, not a dose.
- Immune Boosting
- Anti-inflammatory
- Healing
- Inflammation Resolution
- US status
- Research Chemical
- Approval
- Not Approved by FDA/EMA
- Evidence
- Synthetic tetrapeptide bioregulator. Investigated for chronic obstructive pulmonary disease (COPD) and asthma adjunct therapy.
- Research score
- 70 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- Russia
- Source category
- Immune System
- Status group
- Research chemical
Mechanism
Thought to act on immune cells in bronchial tissue via JAK/STAT signaling, balancing cytokine output, boosting macrophage activity while curbing IL-6 and TNF-α, and supporting T-cell regulation and epithelial barrier integrity.
Safety file
Marketed as side-effect-free, but rigorous human trial data is absent; preclinical tolerability appears good.
- Injection site reactions
- Temporary immune system fluctuations
- Mild respiratory sensitivity